Search results

Researchers and industry partners from UNSW Australia, the Australian Centre for Nanomedicine, Children’s Cancer Institute and Inventia Life Sciences Pty Ltd have been awarded the 2021 ANSTO Eureka Prize for Innovative Use of Technology for their method to rapidly-produce 3D cell structures

The need for a smaller, more transportable version of ANSTO’s 1500-litre atmospheric radon-222 monitor, and with a calibration traceable to the International System of Units, prompted the team to develop a 200-litre radon monitor that would meet those needs.

Professor of Soil Science at The University of Queensland, Peter Kopittke and partner investigator Prof Enzo Lombi of the University of SA are very optimistic about the use of a new synchrotron-based imaging technique that captures in 3D the complex interaction of soil and root.

In 2023 we’re celebrating the 70th Anniversary since Australia began developing our nation’s Australia’s nuclear capabilities.

ANSTO welcomes the recent announcement that the inaugural CEO for the Australian Radioactive Waste Agency (ARWA) has been appointed, following a global search. Mr Sam Usher will lead ARWA and comes to the role with almost three decades of experience in the nuclear industry. 

COVID-19 can’t stop kids with a passion for science and technology, with ANSTO launching our new online STEAM Club just in time for the school holidays.

The ANSTO Awards in Nuclear Science and Technology 2018 were presented on Friday 2 November at The Australian Museum, and showcased ANSTO’s unique nuclear science and technology capabilities, which enable progress in the key areas of health research and innovation for industry.

Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia

Swinburne University of Technology is launching an Australian-first Aerostructures Innovation Research Hub (AIR Hub) with the support of $12 million in funding from the Victorian Government.

ANSTO has a role in the global monitoring system on behalf of Australia to ensure non-proliferation of weapons and that nuclear technology is only used for peaceful purposes.

ANSTO announces the recipients of the 2022 organisational awards

ANSTO has been licensed as the Australian manufacturing partner of an innovative, non-invasive treatment for non-melanoma skin cancer (NMSC).